Funding search · EIN 366975534 · Dallas, TX
Dr Ralph & Marian Falk Medical Research Tr
Search the web for this foundation ↗Full IRS filings ↗
- $32.5M
- in grants paid
- 141
- grants
- 38
- recipients
- 2021–2024
- filing years
Recent grants
The 100 largest recent grants from this foundation’s filings, newest year first.
- $355,809
Case Western Reserve University · Cleveland, OH · 2024
Immunotherapy for b cell
- $348,252
Yale University - School of Medicine · New Haven, CT · 2024
Making cancer cells look
- $340,879
Indiana University · Bloomington, IN · 2024
Pim2 modulator-multiple
- $334,583
Medical College of Wisconsin · Milwaukee, WI · 2024
Pain therapy - sensory
- $333,333
Thomas Jefferson University · Philadelphia, PA · 2024
Protacs for targeting brca
- $331,873
Cleveland Clinic Foundation · Cleveland, OH · 2024
Development of new drug for
- $330,487
Board Regents of University of Wisconsin · Milwaukee, WI · 2024
Improve diagnosis of breast
- $315,981
Medical College of Wisconsin · Milwaukee, WI · 2024
New drugs to treat
- $308,897
Universityof Minnesota · Minneapolis, MN · 2024
T3 therapy - heart failure
- $284,681
University of Minnesota · Minneapolis, MN · 2024
Optimized mechanism based
- $268,735
University of Chicago · Chicago, IL · 2024
Metastic lung cancer phase
- $257,044
Purdue University · West Lafayette, IN · 2024
Advancing micro rnas as
- $210,398
Northwestern University · Evanston, IL · 2024
Therapy for chronic kidney
- $208,319
University of Iowa · Iowa City, IA · 2024
Vascular health targeting
- $203,837
University of Minnesota · Minneapolis, MN · 2024
Systemic bacteremia - host
- $186,955
Cleveland Clinic Foundation · Cleveland, OH · 2024
Treatment of complex
- $178,604
Ohio State University · Columbus, OH · 2024
Melanoma onset & recurrence
- $176,327
University of Minnesota · Minneapolis, MN · 2024
Develop il-15 - malaria
- $175,864
Shirley Ryan Ability Lab · Chicago, IL · 2024
Restore diaphragm - nerve
- $175,575
Mayo Clinic · Rochester, MN · 2024
Cd-19 targeted car-msc19 in
- $175,000
University of Cincinnati · Cleveland, OH · 2024
Develop improved method of
- $175,000
Washington University · St Louis, MO · 2024
Stem cell derived islets
- $175,000
Brown University of Providence · Providence, RI · 2024
Repurposing clopidogrel to
- $175,000
Loyola University of Chicago · Chicago, IL · 2024
Inhibitors for triple
- $175,000
Case Western Reserve University · Cleveland, OH · 2024
Pharma strategy to treat
- $175,000
Michigan State University · East Lansing, MI · 2024
Develop new odc inhibitors
- $175,000
Regents of University of Michigan · Ann Arbor, MI · 2024
Neuro-cardiac mechanisms of
- $175,000
Regents of University of Michigan · Ann Arbor, MI · 2024
Antibody cns delivery and
- $173,839
University of Minnesota · Minneapolis, MN · 2024
Sound waves assessment via
- $173,769
Children'S Hospital Medical Center · Cincinnati, OH · 2024
Autoimmune arthritis
- $173,717
Washington University · St Louis, MO · 2024
Vagus nerve stimulation -
- $173,096
Brown University of Providence · Providence, RI · 2024
Gene therapy for
- $169,910
Indiana University · Bloomington, IN · 2024
Traumatic brain injury
- $168,188
Northwestern University · Evanston, IL · 2024
Antibodies treatment of
- $161,487
Yale University - School of Medicine · New Haven, CT · 2024
Anti vb2 antibody drug for
- $151,908
Ohio State University · Columbus, OH · 2024
Develop new therapy for
- $150,426
University of Minnesota · Minneapolis, MN · 2024
Severity measure- adductor
- $57,018
Indiana University · Bloomington, IN · 2024
Inhibitors-peanut specific
- $497,018
University of Cincinnati · Cleveland, OH · 2023
Inhibitors targeting peanut
- $495,146
Brown University of Providence · Providence, RI · 2023
Anti-malaria drugs targetng
- $377,004
Medical College of Wisconsin · Milwaukee, WI · 2023
New drugs to treat
- $343,159
Case Western Reserve University · Cleveland, OH · 2023
B cell cancer therapy using
- $336,255
Cleveland Clinic Foundation · Cleveland, OH · 2023
Development of new drug for
- $333,333
Thomas Jefferson University · Philadelphia, PA · 2023
Protacs for targeting brca
- $318,948
Medical College of Wisconsin · Milwaukee, WI · 2023
Development of sensory
- $235,086
Universityof Minnesota · Minneapolis, MN · 2023
Thyroid hormone
- $200,685
University of Chicago · Chicago, IL · 2023
Tumor anueploidy -
- $197,879
Ohio State University · Columbus, OH · 2023
Develop new therapy for
- $190,000
Yale University School of Medicine · New Haven, CT · 2023
Targeted degredation of
- $190,000
Regents of University of Michigan · Ann Arbor, MI · 2023
Device to predict
- $190,000
Childrens Hospital Medical Center · Cincinnati, OH · 2023
Lupus nephritis biomarkers
- $190,000
Cleveland Clinic Foundation · Cleveland, OH · 2023
New weapons to fight
- $187,210
State University of Iowa · Iowa City, IA · 2023
Improve hypoxic tumor mgmt
- $181,905
Mayo Clinic · Rochester, MN · 2023
In vivo generation of car t
- $179,775
Indiana University · Bloomington, IN · 2023
Traumatic brain injury
- $177,796
Rehabilitation Institute of Chicago · Chicago, IL · 2023
Repurpose 5-azacytidine -
- $177,271
Indiana University · Bloomington, IN · 2023
Novel minimally invasive
- $176,215
Stanford University · Stanford, CA · 2023
Metabolic pausing - organ
- $175,216
Washington University · St Louis, MO · 2023
Zika virus genetic arming-
- $175,000
Board Regents of University of Wisconsin · Milwaukee, WI · 2023
Diabetes stem cell cure -
- $175,000
University of Cincinnati · Cleveland, OH · 2023
Develop improved method of
- $175,000
University of Chicago · Chicago, IL · 2023
Development of syngap1
- $175,000
Michigan State University · East Lansing, MI · 2023
Develop new odc inhibitors
- $175,000
Brown University of Providence · Providence, RI · 2023
Repurposing clopidogrel to
- $175,000
Case Western Reserve University · Cleveland, OH · 2023
Blocking peptide treatment
- $174,425
Mayo Clinic · Rochester, MN · 2023
Cd-19 targeted car-msc19 in
- $173,673
University of Minnesota · Minneapolis, MN · 2023
Develop il-15 - malaria
- $173,017
Yale University School of Medicine · New Haven, CT · 2023
Develop phage therapy to
- $168,835
University of Minnesota · Minneapolis, MN · 2023
Severity measure- adductor
- $163,974
Stanford University · Stanford, CA · 2023
Novel dna-guided argonaute
- $150,887
Thomas Jefferson University · Philadelphia, PA · 2023
Chemokine antagonist for
- $145,339
University of Cincinnati · Cleveland, OH · 2023
Targeting sexual cycle of
- $136,995
University of Cincinnati · Cleveland, OH · 2023
Letrozole- novel
- $100,000
Indiana University · Bloomington, IN · 2023
Novel rxr agonist for
- $18,026
Northwestern University · Evanston, IL · 2023
T cell therapy for
- $504,854
Brown University of Providence · Providence, RI · 2022
Anti-malaria drugs targetng
- $445,923
Indiana University · Bloomington, IN · 2022
Targeting peanut-specific
- $346,469
Medical College of Wisconsin Sen Neuron · Milwaukee, WI · 2022
Development of sensory
- $333,333
Thomas Jefferson University · Philadelphia, PA · 2022
Protacs for targeting brca
- $331,974
Northwestern University · Evanstone, IL · 2022
T cell thearpy for
- $301,032
Case Western Reserve University · Cleveland, OH · 2022
B cell cancer therapy using
- $211,322
University of Cincinnati · Cleveland, OH · 2022
Studies for repurposing
- $204,619
University of Cincinnati · Cleveland, OH · 2022
Targeting sexual cycle of
- $200,000
Cleveland Clinic Foundation · Cleveland, OH · 2022
New weapons to fight
- $200,000
Regents of University of Michigan · Ann Arbor, MI · 2022
Device to predict
- $200,000
Childrens Hospital Medical Center · Cincinnati, OH · 2022
Lupus nephritis biomarkers
- $200,000
Yale University School of Medicine · New Haven, CT · 2022
Targeted degredation of
- $196,613
Thomas Jefferson University · Philadelphia, PA · 2022
Chemokine antagonist for
- $190,000
Childrens Hospital Medical Center · Cincinnati, OH · 2022
Develop human liver
- $190,000
Stanford University - Development Services · Redwood City, CA · 2022
Novel therapies - major
- $190,000
Board Regents of University of Wisconsin · Milwaukee, WI · 2022
Nanoparticles target
- $175,188
Yale University School of Medicine · New Haven, CT · 2022
Develop phage therapy to
- $175,000
Case Western Reserve University · Cleveland, OH · 2022
Blocking peptide treatment
- $175,000
University of Chicago · Chicago, IL · 2022
Development of syngap1
- $175,000
Board Regents of University of Wisconsin · Milwaukee, WI · 2022
Diabetes stem cell cure -
- $174,784
Washington University · St Louis, MO · 2022
Zika virus genetic arming-
- $173,785
Stanford University - Development Services · Redwood City, CA · 2022
Metabolic pausing - organ
- $172,729
Indiana University · Bloomington, IN · 2022
Novel minimally invasive
- $171,431
Rehabilitation Institute of Chicago · Chicago, IL · 2022
Repurpose 5-azacytidine -
- $168,095
Mayo Clinic · Minneapolis, MN · 2022
In vivo generation - car t
Grants already paid are the record; PaperOrbit reads your paper and finds the foundations whose record matches it — then explains why.
Start with one paperSource: IRS Form 990-PF, Part XV, as filed by the foundation. These are grants already paid — a record of what this funder backs, not an open call. Most private foundations do not accept unsolicited applications; the route in is usually a program officer.

